Definitive Contract HHSF223201610075C
Award Date
8/19/16
Potential Completion Date
4/30/18
Potential Value
$308K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Denver, CO 80204, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
73
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $630,211.00, was issued by the Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health), a comprehensive healthcare system based in Denver, Colorado. The contract is for understanding the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among the general population through an online panel survey. The contract is a firm-fixed-price delivery order and is not designated as a...
This firm fixed-price delivery order was awarded to Denver Health and Hospital Authority, doing business as Denver Health, by the Food and Drug Administration (FDA). The $87,552.08 contract is for Denver Health to provide the RADARS StreetRx dataset and RADARS drug diversion services to support the FDA's post-marketing prescription and over-the-counter drug abuse surveillance efforts. This work is being performed under the FDA Prescription Drug Abuse Summary Reports indefinite...
Denver Health and Hospitals Authority has been awarded a firm fixed price delivery order against the FDA's contract vehicle for $205,010. The order is for a survey of non-medical use of prescription drugs to collect data on selected drugs of interest. Performance will take place in Denver, Colorado and be completed by September 1, 2024. No set-aside designation was used for this order. As the prime contractor, Denver Health will provide data collection and analytics services to the Food and Drug...
The Department of Health and Human Services Food and Drug Administration awarded a $435,308.00 Firm Fixed Price Definitive Contract to Childrens Hospital Medical Center, doing business as Children's Home Healthcare, for the development of a Preventable Harm from Pediatric Outpatient Medication Errors Measure. The contract does not have a set-aside designation. Childrens Hospital Medical Center, a non-profit hospital located in Cincinnati, Ohio, has a history of performing medical research,...
This is a delivery order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The $451,070 contract is for a randomized controlled clinical trial to evaluate the efficacy, safety, and acceptability of the female contraceptive C31G. The contract does not have any set-aside designations. The University of Colorado-Denver is a major public research...
The federal contract award HHSF223201510122C was issued by the Food and Drug Administration (FDA), a civilian agency, to the Arkansas Department of Health (ADH) in Little Rock, Arkansas. This is a definitive, firm-fixed price contract with a ceiling value of $408,478.22 and a completion date of September 29, 2018. The contract is for an "Arkansas Food Contract" and was not set aside. ADH, as a state government entity, has received various federal contracts and grants from agencies like...
<p>The U.S. Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $193,820.00 firm fixed price purchase order contract to Aspen Research Corporation, a self-certified small disadvantaged business, for polymer compounding and evaluating leachable exposure. The contract has a completion date of September 23, 2023 and was awarded on September 24, 2021. The contract is not set aside.</p>
The Department of Health and Human Services Food and Drug Administration awarded a $2,082,291.00 firm fixed price definitive contract to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, Massachusetts. The contract is for "Effectiveness Research with Real World Data to Support FDA's Regulatory Decision Making." It does not have a set-aside designation. Under the contract, Brigham & Women's Hospital is working closely with the FDA's...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order contract to Biomedical Research Foundation of Central Arkansas, a non-profit organization, for $344,340.00. The contract is for electronic medical records (EMR) data extraction services related to drug-induced cardiovascular abnormalities. This contract does not have a set-aside designation. Biomedical Research Foundation has previously provided medical research services to...
This $14,247,561.28 federal contract was awarded by the Food and Drug Administration (FDA) to Deloitte & Touche LLP for the modernization of the FDA Center for Drug Evaluation and Research's (CDER) Drug Supply Identification and Trace Drug Shortage System. The contract was a call order under Deloitte's existing CDER Information Technology Support And Program Management Support Services Blanket Purchase Agreement (BPA). The work does not have a set-aside designation. Major subcontractors...